| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 60.2242 | 65 |
| GSM780708 | Untreated after 4 days (C2_1) | 54.4045 | 59 |
| GSM780709 | Untreated after 4 days (C3_1) | 52.1517 | 54 |
| GSM780719 | Untreated after 4 days (C1_2) | 45.3861 | 29 |
| GSM780720 | Untreated after 4 days (C2_2) | 56.3042 | 61 |
| GSM780721 | Untreated after 4 days (C3_2) | 47.7416 | 40 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 60.2782 | 65 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 56.4129 | 61 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 56.1731 | 61 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 58.6182 | 63 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 55.191 | 60 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 52.7861 | 56 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 56.9868 | 62 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 49.186 | 46 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 49.5965 | 47 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 53.4703 | 57 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 56.2321 | 61 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 53.7147 | 57 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 72.39 | 70 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 50.5634 | 50 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 53.0825 | 56 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 55.5041 | 60 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 59.264 | 64 |